| Dr Laurie M Hill, MD | |
|
1420 E College Dr, Marshall, MN 56258 | |
| (507) 532-9631 | |
| (507) 532-1176 |
| Full Name | Dr Laurie M Hill |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 1420 E College Dr, Marshall, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356317143 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 30350 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera At Home Marshall | Marshall, MN | Home health agency |
| Avera Marshall Regional Medical Ctr | Marshall, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rural Health Care Inc | 3476447541 | 130 |
News Archive
Back pain is among the most frequently reported health problems in the world. New research published in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, examines patterns in back pain over time and identifies the patient characteristics and the extent of healthcare and medication use (including opioids) associated with different patterns.
Superheroes, Minions, pint-sized princesses and a cowboy invaded the hallways of St. Joseph's Children's Hospital in Tampa today. Some came on foot, others arrived in little red wagons and wheelchairs, and all were in search of Halloween goodies.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
RaySearch Laboratories AB has received FDA 510(k) clearance for its RayStation® treatment planning system.
› Verified 2 days ago
| Entity Name | Avera Marshall |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568401016 PECOS PAC ID: 5799695227 Enrollment ID: O20031106000219 |
News Archive
Back pain is among the most frequently reported health problems in the world. New research published in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, examines patterns in back pain over time and identifies the patient characteristics and the extent of healthcare and medication use (including opioids) associated with different patterns.
Superheroes, Minions, pint-sized princesses and a cowboy invaded the hallways of St. Joseph's Children's Hospital in Tampa today. Some came on foot, others arrived in little red wagons and wheelchairs, and all were in search of Halloween goodies.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
RaySearch Laboratories AB has received FDA 510(k) clearance for its RayStation® treatment planning system.
› Verified 2 days ago
| Entity Name | Avera Marshall |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1568401016 PECOS PAC ID: 5799695227 Enrollment ID: O20091209000435 |
News Archive
Back pain is among the most frequently reported health problems in the world. New research published in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, examines patterns in back pain over time and identifies the patient characteristics and the extent of healthcare and medication use (including opioids) associated with different patterns.
Superheroes, Minions, pint-sized princesses and a cowboy invaded the hallways of St. Joseph's Children's Hospital in Tampa today. Some came on foot, others arrived in little red wagons and wheelchairs, and all were in search of Halloween goodies.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
RaySearch Laboratories AB has received FDA 510(k) clearance for its RayStation® treatment planning system.
› Verified 2 days ago
| Entity Name | Rural Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215317375 PECOS PAC ID: 3476447541 Enrollment ID: O20150710000034 |
News Archive
Back pain is among the most frequently reported health problems in the world. New research published in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, examines patterns in back pain over time and identifies the patient characteristics and the extent of healthcare and medication use (including opioids) associated with different patterns.
Superheroes, Minions, pint-sized princesses and a cowboy invaded the hallways of St. Joseph's Children's Hospital in Tampa today. Some came on foot, others arrived in little red wagons and wheelchairs, and all were in search of Halloween goodies.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
RaySearch Laboratories AB has received FDA 510(k) clearance for its RayStation® treatment planning system.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laurie M Hill, MD 1420 E College Dr, Marshall, MN 56258 Ph: (507) 532-9631 | Dr Laurie M Hill, MD 1420 E College Dr, Marshall, MN 56258 Ph: (507) 532-9631 |
News Archive
Back pain is among the most frequently reported health problems in the world. New research published in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, examines patterns in back pain over time and identifies the patient characteristics and the extent of healthcare and medication use (including opioids) associated with different patterns.
Superheroes, Minions, pint-sized princesses and a cowboy invaded the hallways of St. Joseph's Children's Hospital in Tampa today. Some came on foot, others arrived in little red wagons and wheelchairs, and all were in search of Halloween goodies.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
RaySearch Laboratories AB has received FDA 510(k) clearance for its RayStation® treatment planning system.
› Verified 2 days ago
Dr. Jane Elise Hartman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 South Bruce Street, Avera Marshall, Marshall, MN 56258 Phone: 507-537-9007 Fax: 507-537-2730 | |
Dr. Terence James Parr, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-537-9830 Fax: 507-537-9144 | |
Idriss Ibrahim, CNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 309 E College Dr, Marshall, MN 56258 Phone: 507-530-6028 | |
Dr. Steven T Meister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-532-9661 | |
Michael K Anyasike, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Bruce St, Marshall, MN 56258 Phone: 507-532-9661 | |
Stephanie A Mckee, PA C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1420 East College Drive, Marshall, MN 56258 Phone: 507-532-9631 Fax: 507-532-1176 |